Details

Autor(en) / Beteiligte

• Wandall, Hans H.
• Nielsen, Mathias A. I.
• King‐Smith, Sarah
• Haan, Noortje
• Bagdonaite, Ieva

Titel

Global functions of O‐glycosylation: promises and challenges in O‐glycobiology

Ist Teil von

• The FEBS journal, 2021-12, Vol.288 (24), p.7183-7212

Ort / Verlag

England: Blackwell Publishing Ltd

Erscheinungsjahr

2021

Quelle

MEDLINE

Beschreibungen/Notizen

• Mucin type O‐glycosylation is one of the most diverse types of glycosylation, playing essential roles in tissue development and homeostasis. In complex organisms, O‐GalNAc glycans comprise a substantial proportion of the glycocalyx, with defined functions in hemostatic, gastrointestinal, and respiratory systems. Furthermore, O‐GalNAc glycans are important players in host–microbe interactions, and changes in O‐glycan composition are associated with certain diseases and metabolic conditions, which in some instances can be used for diagnosis or therapeutic intervention. Breakthroughs in O‐glycobiology have gone hand in hand with the development of new technologies, such as advancements in mass spectrometry, as well as facilitation of genetic engineering in mammalian cell lines. High‐throughput O‐glycoproteomics have enabled us to draw a comprehensive map of O‐glycosylation, and mining this information has supported the definition and confirmation of functions related to site‐specific O‐glycans. This includes protection from proteolytic cleavage, as well as modulation of binding affinity or receptor function. Yet, there is still much to discover, and among the important next challenges will be to define the context‐dependent functions of O‐glycans in different stages of cellular differentiation, cellular metabolism, host–microbiome interactions, and in disease. In this review, we present the achievements and the promises in O‐GalNAc glycobiology driven by technological advances in analytical methods, genetic engineering, and systems biology. With a genetic entry point and new technologies, we are beginning to define functions related to mucin‐type O‐glycosylation. This includes protection from proteolytic cleavage, modulation of receptor functions, homing and modulation of immune cells, and functions in cell adhesion, metabolism, and host–microbiome interactions. This review presents the achievements and promises in O‐GalNAc glycobiology driven by technological advances in analytical methods, genetic engineering, and systems biology.